论文部分内容阅读
近年阿霉素（ADM）应用治疗肿瘤的效果报道不少，但它的剧作用尤其是对心脏毒性作用构成了限制其应用的重要因素。现将我院应用阿霉素为主联合治疗肿瘤患者病例加以分析如下。1资料与方法：收集我院经阿霉素为联合方案化疗的患者共93例，其中男57例，女36例；平均年龄55．6岁；
In recent years, the efficacy of adriamycin (ADM) in the treatment of cancer has been reported, but its dramatic effects, especially on cardiotoxicity, constitute an important factor limiting its application. Now our hospital doxorubicin-based treatment of cancer patients to be analyzed as follows. 1 Materials and Methods: 93 cases of adriamycin-receiving chemotherapy in our hospital were collected, including 57 males and 36 females with an average age of 55.6 years.